Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperthyroxinemia in major affective disorders.

R Styra1, R Joffe, W Singer

  • 1Department of Psychiatry, St. Michael's Hospital, Toronto, Ontario, Canada.

Acta Psychiatrica Scandinavica
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accuracy of chat-based artificial intelligence for patient education on orthostatic hypotension.

Clinical autonomic research : official journal of the Clinical Autonomic Research Society·2025
Same author

[Differentiating cochlear synaptopathies into different hearing disorders].

HNO·2019
Same author

Neurofeedback Training of Gamma Oscillations in Monkey Primary Visual Cortex.

Cerebral cortex (New York, N.Y. : 1991)·2019
Same author

Cerebral oximetry and postoperative delirium after cardiac surgery: a randomised, controlled trial.

Anaesthesia·2017
Same author

Ultrahigh molecular weight polyethylene/graphene oxide nanocomposites: Wear characterization and biological response to wear particles.

Journal of biomedical materials research. Part B, Applied biomaterials·2016
Same author

Delirium after transcatheter aortic valve implantation via the femoral or apical route.

Anaesthesia·2016
Same journal

Developmental Trauma as a Prognostic Factor for Later Psychotic Disorder in an Adolescent Clinical Cohort: A 20-Year Follow Up Study.

Acta psychiatrica Scandinavica·2026
Same journal

The Prevalence of Obstructive Sleep Apnoea in Schizophrenia, Bipolar Disorder and Major Depressive Disorder: A Systematic Review With Meta-Analysis.

Acta psychiatrica Scandinavica·2026
Same journal

Use of Glucagon-Like Peptide 1 Receptor Agonists and the Associated Risk of Hospitalisation in Bipolar Disorder, From a Nationwide Cohort, 2009-2024.

Acta psychiatrica Scandinavica·2026
Same journal

Benzodiazepine Use and Mortality Risk: A Nationwide Cohort Study on New Benzodiazepine Users With a 5-Year Follow-Up.

Acta psychiatrica Scandinavica·2026
Same journal

Leveraging Family Genetic Risk Scores to Understand the Etiology of Suicidal Behaviors and Their Associations With Psychiatric Disorders.

Acta psychiatrica Scandinavica·2026
Same journal

Does the Loss of Autobiographical Memories Contribute to the Therapeutic Effect of Electroconvulsive Therapy?

Acta psychiatrica Scandinavica·2026
See all related articles

A study found 12% of patients with major affective disorder had elevated thyroxine levels. However, this thyroid condition did not affect their response to standard antidepressant treatments.

Area of Science:

  • Endocrinology
  • Psychiatry
  • Neuroscience

Background:

  • Major affective disorders, including bipolar and unipolar depression, are significant mental health conditions.
  • Thyroid hormone levels, particularly thyroxine, are known to influence mood and cognitive function.
  • Previous research suggests a potential link between thyroid dysfunction and mood disorders.

Purpose of the Study:

  • To investigate the prevalence of elevated thyroxine levels in patients diagnosed with primary major affective disorder.
  • To determine if hyperthyroxinemia impacts the efficacy of antidepressant treatment in this patient population.

Main Methods:

  • Ninety-nine patients meeting DSM-III criteria for major affective disorder (bipolar or unipolar) were enrolled.
  • Serum thyroxine levels were measured to identify individuals with hyperthyroxinemia.

Related Experiment Videos

  • Patients received standard antidepressant treatment, and treatment response was compared between groups.

    • Main Results:

    • A prevalence of 12% for elevated thyroxine levels was observed among the studied patients.
    • Three out of twelve patients with hyperthyroxinemia also exhibited an elevated free thyroxine index.
    • No statistically significant difference in antidepressant treatment response was found between hyperthyroxinemia and normal serum thyroxine groups.

    Conclusions:

    • Elevated thyroxine levels are present in a notable subset of patients with major affective disorder.
    • Hyperthyroxinemia does not appear to be a predictor of differential response to common antidepressant therapies.
    • Further research may explore the specific role of thyroid function in mood regulation and treatment resistance.